Skip to main content
. 2014 May 29;16(4):810–842. doi: 10.1208/s12248-014-9591-x

Table I.

Glossary for Parameters and Variables

 Parameter/variable (unit) Definition References/remarks
Full PBPK model
 - Parameters
   K 0 (M/h) Endogenous IgG production rate (13)
   Q organ (L/h) Plasma Flow rate to each organ (10)
   L organ (L/h) Lymphatic Flow rate to each organ (10)
  CLOrganUptake  (L/h) Endosomal uptake rate of unbound antibody (13)
  CLOrganProteolysis (L/h) Clearance rate of unbound antibody via proteolytic degradation in the endosome Same value for CL OrganUptake.
   k on-X (M−1 h−1) mAb-FcRn association constant in each subendosomal compartment X (13) Assumed similar for IgG and mAb
   k off-X (h−1) mAb-FcRn dissociation constant in each subendosomal compartment X (13) Assumed similar for IgG and mAb
  KA (M)−1 Equilibrium binding association affinity Inline graphic
  RtotalOrgan ‐ X  (moles) Initial amount of free FcRn receptor in subendosomal compartment X obtained by multiplying FcRn concentration reported in (13) by V OrganEND
   F return  (no units) Fraction of antibody returning from lymph node to plasma Inline graphic (13)
   τ (h) Transit time between endosomal compartments (13) (0.045)
  TauLN (h) Transit time from lymph node to plasma (13) (9.1)
   σ VAS  (no unit) Vascular reflection coefficient Same for all organs (0.95) (11)
   σ LY  (no unit) Lymph reflection coefficient Same for all organs (0.2)
  FR (no unit) Recycling fraction of the bound antibody from endosomal to vascular and interstitial subcompartments (11) (0.715)
   V OrganVAS  (L) Volume of vascular compartment in each organ (11)
   V OrganISF  (L) Volume of interstitial compartment in each organ (11)
   V OrganEND  (L) Volume of each endosomal subcompartment in each organ (11)
   V Plasma  (L) Volume of plasma (11)
 - Variables
   A JPlasma (moles) Amount of endogenous IgG or mAb in plasma
   A JLN (moles) Amount of endogenous IgG or mAb in lymph node
   A JVAS Organ (moles) Amount of endogenous IgG or mAb in vascular space
   A JISF Organ (moles) Amount of endogenous IgG or mAb in interstitial space
   A JEND Organ ‐ X (moles) Amount of endogenous IgG or mAb in subendosomal compartment X
  ARCPXJOrgan ‐ X  (moles) Amount of endogenous IgG -FcRn or mAb-FcRn receptor complex in subendosomal compartment X
Step 1 (Fig. 2)
 - Parameters
   k OrganVAS ‐ circul. (h−1) Transfer rate from vascular compartment to lung or, in case of lung, from lung to plasma Inline graphic
   k Organcircul. ‐ VAS (h−1) Transfer rate from plasma to vascular compartment Inline graphic
  (1 − σ VAS) × k OrganLY VAS ‐ ISF (h−1) Transfer from vascular to interstitial compartment via lymphatic flow Inline graphic
   k OrganVAS ‐ EL (h−1) Elimination from vascular compartment Inline graphic
   k OrganVAS ‐ VAS (h−1) Input from vascular compartment to itself. Reflect endosomal contribution to vascular compartment Inline graphic
   k OrganVAS ‐ ISF (h−1) Transfer from vascular to interstitial compartment Inline graphic
   k OrganISF ‐ VAS (h−1) Transfer from interstitial to vascular compartment Inline graphic
  (1 − σ LY) × k OrganLY ISF ‐ LN (h−1) Transfer from interstitial compartment to lymph node via lymphatic flow Inline graphic
   k OrganISF ‐ EL (h−1) Elimination from interstitial compartment Inline graphic
   k OrganISF ‐ ISF (h−1) Input from interstitial compartment to itself. Reflect endosomal contribution to interstitial compartment Inline graphic
  KDEND (moles) Equilibrium dissociation constant for mAb binding to FcRn receptor in amounts Inline graphic
   K 0 (M/h) Endogenous IgG production rate (13)
 - Variables
   A JEND Total Organ ‐ X (moles) Total amount of endogenous IgG or mAb (bound and free) in subendosomal compartment X
Steps 2 and 3 (Fig. 3a and b)
 - Parameters
   Q Visceral (L/h) plasma Flow rate to the visceral compartment Q Heart + Q Kidney + Q Skin + Q Muscle
   Q Splanchnic (L/h) plasma Flow rate to the splanchnic compartment Q GIT + Q Spleen
   L Visceral (L/h) Lymph Flow rate to the visceral compartment L Heart + L Kidney + L Skin + L Muscle
   L Splanchnic (L/h) Lymph Flow rate to the splanchnic compartment L GIT + L Spleen
 - New compartments resulting from model simplification
   Splanchnic GIT and spleen
   Visceral Heart, kidney, skin, and muscle lumped
Steps 4, and 5 (Fig. 3c and d)
 - Parameters
   Q Peripheral (L/h) Plasma Flow rate to the Peripheral compartment Q Visceral + Q Splanchnic
   L Peripheral (L/h) Lymph Flow rate to the Peripheral compartment L Visceral + L Splanchnic
 - New compartments resulting from lumping
   Peripheral Visceral and splanchnic
Step 6 (Fig. 3e)
 - Parameters
   k CentralEL (h−1) Elimination rate from the central compartment
  (1 − σ VAS) × k CentralLY Central ‐ Per (h−1) Transfer rate from the central to interstitial (i.e., peripheral) compartment via lymphatic flow
   k CentralCentral (h−1) First-order input from central compartment to itself which reflects the impact of recycled drug from endosomal compartment
   k CentralCentral ‐ ISF (h−1) First-order input from central to interstitial (i.e., peripheral) compartment
   k PeripheralISF ‐ Central (h−1) Transfer from interstitial (i.e., peripheral) to central compartments
  (1 − σ LY) × k PeripheralLY ISF ‐ LN (h−1) Transfer from interstitial (i.e., peripheral) compartment to lymph node via lymphatic flow
   k PeripheralISF ‐ ISF (h−1) Input from Peripheral compartment to itself. Reflect endosomal contribution to interstitial compartment
   Inline graphic (h−1) Transfer from lymph node to Central compartment
 Variables
   A Central (moles) Amount of mAb in the central compartment (i.e., plasma and Vascular subcompartments in equilibrium)
   A Peripheral (moles) Amount of mAb in the Peripheral compartment
Step 7 (Fig. 3f)
 - Parameters
   k CEL (h−1) Elimination rate from the central compartment after subtracting the contribution of the endosomal compartment
   k PEL (h−1) Elimination rate from the peripheral compartment after subtracting the contribution of the endosomal compartment
   k Cen ‐ Per (h−1) Reflection of the fraction mAb-FcRn complex recycled
  (1 − σ VAS) × k CentralLY ‐ ISF (h−1) Transfer of the mAb from Central to Peripheral compartments via lymphatic flow
   k CP (h−1) Transfer of the mAb from Central to Peripheral compartments via two processes, a- the lymphatic flow and b- the reflection of the fraction mAb-FcRn complex recycled (1 − σ VAS) × k CentralLY ‐ ISF + k CentralCentral ‐ ISF
  (1 − σ LY) × k PeripheralLY ISF ‐ LN (h−1) Transfer from interstitial (i.e., peripheral) compartment to lymph node via lymphatic flow
   Inline graphic (h−1) Transfer from lymph node to Central compartment
Final simplified model (Fig. 4)
 - Parameters
   V C (L) Volume of the Central Compartment
   k EL (h−1) Elimination rate from the central and peripheral compartments
   k CP (h−1) Transfer of the mAb from Central to Peripheral compartments via two processes, a- the lymphatic flow and b- the reflection of the fraction mAb-FcRn complex recycled (1 − σ VAS) ∗ k CentralLY − ISF + k CentralCentral − ISF
   k LN (h−1) Transfer from interstitial (i.e., peripheral) compartment to lymph node via lymphatic flow and Transfer from lymph node to Central compartment